Naratriptan Morningside Healthcare

Naratriptan, the active ingredient in Naratriptan Morningside Healthcare, is a Triptan presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adults and works by targeting cranial blood vessels and trigeminal nerve pathways. GNH USA supplies Naratriptan Morningside Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naratriptan is a selective serotonin (5‑HT1B/1D) receptor agonist used in the acute management of migraine.

Migraine (acute): Relieves headache pain and associated symptoms when taken at the onset of an attack. Migraine with aura: Reduces the severity of aura‑related symptoms and subsequent headache. Migraine without aura: Provides rapid relief of headache intensity and associated nausea.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dry mouth: reduced salivation. - Drowsiness: transient sleepiness. - Fatigue: feeling of tiredness. - Tingling sensation: mild paresthesia. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Chest pain or tightness: possible cardiac ischemia. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Severe allergic reaction: rash, swelling, breathing difficulty. - Stroke or transient ischemic attack: rare cerebrovascular events. - Hypertensive crisis: sudden high blood pressure. - Hepatic dysfunction: abnormal liver enzymes.

Before using Naratriptan, consider the following safety measures.

Cardiovascular assessment: Evaluate history of heart disease or uncontrolled hypertension. Avoid in ischemic heart disease: Contraindicated in recent myocardial infarction. Serotonergic drugs: Use caution with SSRIs, SNRIs, or MAO inhibitors. Dose limitation: Do not exceed the maximum number of doses per month as prescribed. Pregnancy and lactation: Discuss risks with a healthcare professional. Store at room temperature: Keep in the original packaging, protect from moisture and direct sunlight.

Naratriptan may interact with several medication classes.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension. - Ergot alkaloids: additive vasoconstriction. - Other triptans: cumulative serotonergic effect.

Moderate Interactions (Monitor Closely): - SSRIs/SNRIs: potential for serotonin syndrome. - Antihypertensives: may enhance blood‑pressure lowering. - CYP3A4 inhibitors: increased naratriptan plasma levels.